Follow us
EN
EN

One of the main goals of Life4me+ — is to prevent new cases of HIV and other STIs, hepatitis C and tuberculosis.

The app helps to establish anonym communication between physicians and HIV-positive people. It allows you to conveniently organize your medication intake timetable and set concealed and personalized reminders.

All news

Archive

✕
24 August 2017
8113
Transgender Women Have Suspicions About The Way ARV Drugs Correlate with Hormones

Transgender Women Have Suspicions About The Way ARV Drugs Correlate with Hormones

At the 9th International AIDS Society Conference on HIV Science (IAS 2017) last month in Paris was announced that transgender women with HIV-positive status have lower adherence to antiretroviral drugs because of their suspicions about the way ARV drugs correlate with feminising ...
24 August 2017
7650
Vast improvement in HIV prevention in Australia

Vast improvement in HIV prevention in Australia

Australian New South Wales has all the chances to achieve UNAIDS goal of HIV elimination by the year 2020. In the first half of this year, men who have sex with men (MSM) were diagnosed with HIV in 40 percent rarely than in the last six years. Such great results had never ...
23 August 2017
7554
Criminalisation of people on HIV treatment should be revised

Criminalisation of people on HIV treatment should be revised

The resulting fear of criminalisation HIV may keep people from getting tested. If a person does not know their HIV status, they can not go on treatment, which is critical for suppressing the virus and preventing further transmissions.
23 August 2017
9655
How PrEP correlates with alcohol or wrong beliefs that stop men who have sex with men to use PrEP

How PrEP correlates with alcohol or wrong beliefs that stop men who have sex with men to use PrEP

PrEP is one of the strongest ways of HIV prevention, just like condoms. Regular PrEP intake shows 90% efficiency of protection against HIV. However, a lot of people refrain from PrEP, because the efficiency of PrEP intake depends on the regularity of medicines intake. Other ...
22 August 2017
7453
Novartis Develops New Drug for Malaria

Novartis Develops New Drug for Malaria

Novartis company announced the start of testing of a new drug for malaria. The pill will contain a combination of KAF156 drug and the other medicine, according to the information of the specialists. Approximately 500 adults and children from a few countries of Asia and Africa ...
21 August 2017
8179
Matthew Hodson: STIs in a post-condoms world

Matthew Hodson: STIs in a post-condoms world

Everybody knows that with an undetectable viral load a human living with HIV could not transmit the virus to his partner. Knowledge of one’s undetectable virus is good, but some specialists working with HIV-positive patients note, that this knowledge may individuals with ...
21 August 2017
9910
Testing for HIV Is Now Compulsory in Zambia

Testing for HIV Is Now Compulsory in Zambia

Individuals wish to be accepted in zambian medical health clinics and centers should test for HIV, announced President Edgar Chagwa Lungu at the launch of HIV Counselling Testing and Treatment Day on 15 August.
18 August 2017
7153
New Discovered Biomarkers May Help In Faster TB Diagnosis and Treatment

New Discovered Biomarkers May Help In Faster TB Diagnosis and Treatment

Researchers from University of Bergen, AIIMS Delhi, Leiden University Medical Center and GlaxoSmithKline Vaccines have tested different biomarkers to find those ones which can help to forecast is Mycobacterium tuberculosis presents or not in a patient, 6 months after treatment. ...
18 August 2017
8684
Switching From Efavirenz to Raltegravir Reduces the Fatty Liver in Patients with HIV and co-infections

Switching From Efavirenz to Raltegravir Reduces the Fatty Liver in Patients with HIV and co-infections

Spanish researchers published the report on reductions in fally liver in patients with HIV while switching to raltegravir from efavirenz in the Clinical Infectious Diseases online edition. About 40 patients with the hepatic steatosis took part in the study and were observed ...
17 August 2017
7868
A Men sentenced for 7 years for Premeditated HIV Transmission in the UK

A Men sentenced for 7 years for Premeditated HIV Transmission in the UK

Antonio Reyes-Minana, a 25-year-old man, was sentenced for 7 years for premeditated HIV transmission in the UK. He had known about his HIV positive status, but this fact didn’t stop him from unprotected sex with two men. Names of his partners couldn’t be disclosed for legal ...
We use cookies on this site to enhance your experience.
By clicking any button on this website you are giving your consent for us to set cookies.